WeVote
Log In

Bill

JR

Bill

A 1838

Establishes New Jersey Active Pharmaceutical Ingredient Regulatory Commission.

2024-2025 Regular Session Introduced by Jessica Ramirez and 1 co-sponsor

New Jersey establishes a dedicated regulatory commission to oversee active pharmaceutical ingredient safety, quality standards, and supply chain integrity within the state.

Introduced in the Assembly, Referred to Assembly Health Committee
#commissions #pharmaceutic
0
WeVote Research Nonpartisan
Bill Summary · A 1838

Legislative bill overview

Bill A 1838 establishes a new regulatory commission in New Jersey specifically focused on active pharmaceutical ingredients (APIs). The commission would oversee the regulation, quality standards, and safety protocols for pharmaceutical ingredients used in drug manufacturing within or distributed through the state.

Why is this important

APIs are the fundamental chemical substances that make medications work, and their quality directly affects drug safety and efficacy. This bill addresses growing concerns about pharmaceutical supply chain integrity, counterfeit ingredients, and contamination risks—issues that have gained attention following international supply chain disruptions and quality scandals involving imported pharmaceutical components.

Potential points of contention

  • Cost and bureaucracy: Creating a new state agency requires funding and staffing; critics may argue this duplicates existing FDA oversight or creates unnecessary state-level regulation
  • Scope and enforcement authority: Unclear whether the commission would have authority over interstate commerce or only intrastate distribution, and how it would coordinate with federal regulators
  • Industry compliance burden: Pharmaceutical manufacturers and distributors may face additional compliance costs and administrative requirements beyond current federal standards
  • Feasibility questions: New Jersey's ability to independently test, certify, or monitor APIs against the resources of the federal FDA remains unclear

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.